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SPECIAL ARTICLES 
Risk factors and predictive indexes of early graft failure 
in liver transplantation 
I.R. MARINO. T.E. STARZL. L. ALDRIGHETTI. C. DORIA, F. MORELLI, TJ.P. GAYOWSKI, 
J.R. MADARIAGA, H.R. DOYLE 
Pittsburgh Transplantation Institllte, University of Pittsburgh Medical Center, and the I Veterans Administration Medi-
cal Cellter. Pittsburgh. PA. USA 
A retrospective analysis of 462 consecutive liver trans-
plantations has been carried out. These were divided 
into two groups, according to whether they failed 
within 90 days (Group I) or survived longer than 90 
days (Group II). Twenty-five donor and recipient va-
riables were analyzed. In the univariate analysis, the 
only donor variable that was significantly different 
between the two groups was age (45.3 ± 16.9 years in 
Group I vs 37.9 ± 15.4 years in Group II, p < 0.001). 
There were five recipient variables significantly· asso-
ciated with early graft failure: history of previous liver 
transplantations (p < 0.0001), United Network for 
Organ Sharing 4 status (p = 0.003), primary diagnosis 
(p = 0.001), preoperative serum creatinine (1.97±1.5 
mg/dL in Group I vs 1.46 ± 1.2 mg/dL in Group II, p = 
0.005), and preoperative total serum bilirubin 
(13.5±14.4 mg/dL in Group I vs 8.4±11.4 mg/dL in 
Group II, p = 0.003). In the multivariate analysis. only 
three variables were independently associated with 
outcome: donor age greater than 45 years, abnormal 
(> 1.5 mg/dL) recipient preoperative creatinine, and a 
history of previous liver transplantation. 
Index terllls: Assessment of outcome model; Early 
graft failur\!: Liver transplantation: Predictors of 
transplantation failure. 
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/ta/illll Associatioll till' rhe Stili/v of rhe Li\'er (Nm'elllber 
1995) 
Over the past 5 years, the yearly pool of cadaveric 
organ donors in the USA has remained stable at 
4,500-5,000 (l). In 1989 there were 2.201 liver tran-
splants (OLTx) performed in this country, increasing 
to 3.650 in 1994. However. this still falls far behind 
the estimated need (2). To meet the increasing de-
mand for organs we need to pursue three parallel stra-
tegies: expanding the donor pool, by better defining 
donor predictors of failure (3-6); investigate alternative 
treatment modalities (bioartificial devices, xenotran-
splantation) (7-9); determine what preoperative fac-
tors, independently or in combination. predict the out-
come of OL Tx. allowing for a better management of 
this scarce resource. 
The purpose of this study was to identify, from 
information that is usually available at the time of 
surgery. what risk factors are associated with early 
graft outcome after OL Tx. 
Patients and methods 
?alient Population From January 1. 1992 to June 30. 
1993. 438 consecutive adult patients received 481 li-
ver transplants at the University of Pittsburgh Medi-
cal Center and the Veterans Administration Medical 
Center, Pittsburgh, PA. In 17 cases. the livers were 
part of multivisceral transplants that included intestine. 
and in other 2 cases were non-human livers (8. 9). 
These cases were not entered for analysis. leaving 
419 recipients of 462 allografts. The information was 
obtained from the clinical database maintained by the 
Pittsburgh Transplantation Institute. and a review of 
the donor charts that are kept on file at the Center for 
Organ Recovery and Education (Western Pennsylva-
nia Organ Procurement Organization) Pittsburgh. PA. 
All grafts were tlushed with the U ni versity of 
Wisconsin (UW) solution. ABO compatibility, size 
match. and medical urgency (UNOS status. see be-
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riod with a documented infection, the decision to 
assign the death to sepsis or ischaemic injury was 
made based on whether there was poor function 
from the very beginning (i.e., a death from sepsis 
in a graft that never functioned well was coded as 
ischaemic injury). An exception to this rule is the pa-
tient who goes into the OL Tx with an unrecognized 
infection (e.g., positive blood cultures which are 
not reported back until after the surgery), in which 
case the death was assigned to sepsis regardless of 
the degree of initial dysfunction. Cases in which 
the early failure was related to MODS (12) were 
also grouped with sepsis; 
6. Other: self-explanatory. 
Table II. Causes of early graft failures (Group I, n=84). 
Rejection* 
Technical 
Ischaemic injury** 
Cardiovascular 
Sepsis-MODS*** 
Other 
Count 
2 
9 
36 
8 
23 
6 
Percentage 
2.4 
10.8 
42.9 
9.5 
27.4 
7.2 
*lnc1udes acute and chroni~ rejection. **Includes primary 
non-function and delayed failure due to harvesting injury. 
***MODS = Multiple Organ Dysfunction Syndrome. Group I 
= early graft failures (within 90 days). 
Statistical Allai.vsis 
Univariate Continuous variables are presented as the 
mean ± standard deviation (SO), and categorical va-
riables as rates. A two-tailed t-test was used to test for 
differences between means, and Pearson's chi-square 
to test for differences between rates. 
Multi\'ariate Variables found. by univariate analysis, 
to be associated with outcome, or whose association 
was of borderline significance, were then used in a 
stepwise logistic regression analysis to identify the 
variables that are independent predictors of outcome. 
In the case of categorical variables. preliminary uni-
variate logistic regression models were fit to determi-
ne if sub-categories should be grouped together. Si-
milarly. in the case of continuous variables prelimi-
nary logistic regression analysis was used to determine 
if they were more appropriately represented as cate-
gorical v<lriables. Models were fit using both forward 
inclusion and backward elimination. with a likelihood 
ratio test. A significance level of O. I was used in the 
stepwise procedure. 
All procedures were performed using SPSS (Stati-
stical Package for the Social Sciences, SPSS, Inc. 
Chicago, Illinois). 
Results 
Demographics Follow-up ranged from 1.12 to 2.6 
years. Of the 462 livers, 452 were transplanted alone 
and the rest were combinations with a kidney (n=4), 
bone marrow (n=4), heart (n=1), and pancreatic islets 
(n=l). The only ABO mismatch, A to 0, was success-
ful. Of the 144 graft losses (31.2%) during the study 
period, 84 (18.20/0) were within the first 90 days 
(early graft failures). 
Effect of putative risk factors As shown in Table III, 
in the univariate analysis the only donor variable that 
was significantly different between the two groups 
was age (p < 0.001). Donor sex reached borderline 
significance (p=0.068). Since the mean harvest 
serum sodium was lower in the early failure group 
(l47±11 mEq/L in Group I vs 150±11 mEq/L in 
Group II, p = 0.09) contrary to reports by other 
groups (13), the analysis was repeated after grouping 
it into physiologically meaningful ranges (Table III). 
Subsequent multivariate analysis used both represen-
tations. 
There were five recipient variables (Table IV) 
Table III. Dunor variables according to outcome. 
Group I Group II Significance 
(n = 84) (n = 378) 
Age (yrs) 4S.3±16.9 37.9±IS,4 p < 0.001 
Female sex ('7c) 4S.2 3·+.7 p = 0.068 
leU LOS (days) 3.8±4.l 3.5±5.1 P = 0.58 
Pressors (%) 42.5 39.7 P = 0.64 
Pitressin (%) 38.8 29.3 p =0.1 
CPR('7c) 16.3 17.3 P = 0.82 
Terminal AST (lUlL) 64±54 76±86 p=0.2 
Terminal AL T (lUlL) 47±40 SI±66 p =0.63 
Ischaemia time (hr) 13.3±2.9 13.3±3.7 P = 0.9 
Harvest serum 
sodium (%) 
< 136 IS.7 7.4 
136 to 145 27.1 27.9 
146 to 160 44.3 47.9 
> 160 12.9 16.8 P =0.15 
Cause of death ('7c): 
Anoxia 6.0 8.0 
Closed head injury 8.3 9.0 
Stroke 52..1- 36..1-
Trauma 22.6 33.0 
Other 10.7 13.6 P = 0.1 
Group I = early graft failures (within 90 days). Group II = 
successful grafts or grafts that failed later (>90 days post-
transplant) 
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Table IV. Recipiellt variables according to outcome. 
Group I Group II Signiticance 
(n = 84) (n = 378) 
Age (yrs) 50.9±12.3 51.0±12.0 p = 0.945 
Sex (mit) 58126 2411137 P = 0.36 
PriorOLTx (%) 33.3 12.2 P = 0.0001 
UNOS 4 status (o/c) 57.1 39.2 P = 0.003 
Waiting time (days) 116±242 151±270 p = 0.283 
Positive cross match (%) 9.6 10.3 p = 0.85 
Preoperative creatinine 1.97±1.5 IA6± 1.2 p = 0.005 
(mg/dL) 
Preoperative bilirubin 13.5±14.-1. 8A±IIA p = 0.003 
(mg/dL) 
Primary diagnosis (lk): 
Alcoholic 14.3 17.2 
Cholestatic 17.9 19.0 
Cryptogenic 14.3 9.8 
FHF 1.2 l.l 
PNF-ischaemia 14.3 2.9 
HCC-cholangio 3.6 7.4 
Metabolic 2A 1.9 
Hepatitic 22.6 30.7 
Rejection l.2 0.3 
Technical 4.8 1.6 
Other 3A 8.1 p=O.OOI 
Group I = early graft failures (within 90 days); Group II = suc-
cessful grafts or grafts that failed later (>90 days post-trans-
plant) 
significantly associated with early graft failure: 
history of previous Ol Tx (p < 0.0001), UNOS 4 sta-
tus (p = 0.003), primary diagnosis (p = 0.001), preo-
perative creatinine (p = 0.005), and preoperative bili-
rubin (p = 0.003). 
The variables that reached significance or borderli-
ne significance were then entered into a stepwise lo-
gistic regression analysis to identify the independent 
predictors of early graft failure. Only three variables 
were independently associated with this outcome: do-
nor age greater than 45 (odds ratio 2.0, 95% CI 1.3 to 
3.3), abnormal (> 1.5 mg/dl) recipient preoperative 
creatinine (odds ratio 1.9, 959'c CI 1.1 to 3.2), and a 
history of previous OlTx (odds ratio 2.7, 95% CI 1.5 
to 5.0). However. when serum creatinine was 
withheld from the analysis, UNOS 4 status then be-
came an independent predictor. 
Eighty-four gmfts failed early, ischaernic injury and sep-
sis-MODS being the leading causes (Table II). 
Discussion 
Since 1982. OL Tx has become definitelv esta-
blished in the treatment of end-stage liver diseases 
( 14). In that year. it was estimated that the annual 
need for OlTx was 15 per million population (14), 
but this is now higher, as the advances of the past de-
cade allow us to treat patients that not long ago, 
would have been considered not transplantable (15). 
But, while in the past, the appropriateness of the deci-
sion to proceed with transplantation was judged lar-
gely on the basis of technical and medical factors re-
lated to the recipient, nowadays it is the supply of or-
gans that increasingly shapes these decisions. The li-
mited supply has been used, at some institutions, to 
justify restricting the availability of the procedure, a 
concept with which we disagree (16). We have pre-
viously demonstrated that, in specific disease catego-
ries, the most important gain in survival is in patients 
that belong in the highest pre transplant risk groups 
(16, 17). Therefore, sicker patients should be treated 
first, but in order to make the best use of our limited 
societal donor resources a number of authors, in the 
last few years, have dedicated their attention to iden-
tify pre-transplant parameters (immunological, bio-
chemical, and clinical) which might be useful in pre-
dicting the outcome of the Ol Tx. Shaw et al. (18) ha-
ve reported the influence, on the six-month survival 
rate after OlTx, of 11 clinical and laboratory varia-
bles in 160 adult liver recipients. In their study, survi-
val at six months was found to correlate inversely 
with operative blood loss, coma, malnutrition, serum 
bilirubin. prothrombin time; and directly with the 
date of transplant. It did not correlate to a significant 
degree with the recipients' age, sex, race, presence of 
ascites, previous surgery, or diagnosis. The effects of 
pre-operative bilirubin and the degree of malnutrition 
(scored on the basis of the serum albumin level) have 
been disputed by Baliga et al. (19) who analyzed 31 
pre-operative variables in a series of 229 adult Ol Tx. 
In their study, admission to the intensive care unit im-
mediately before OlTx. a serum creatinine level> 1.7 
mg/dl, and Child-Pugh class C were associated with a 
significant higher incidence of hospital mortality rate. 
Cuervas-Mons et al. (20) correlated 27 clinical and 
laboratory data with the subsequent clinical course of 
93 adult Ol Tx recipients and found that 7 variables 
(ascites, encephalopathy. elevated white blood cells 
and polymorphonuclear cell count, decreased helper 
to suppressor T cell ratio. and elevated serum creatinine 
and bilirubin levels) were associated with a signiticant-
ly increased risk of mortality. In their series. a serum 
creatinine ~1KqO mg/dl predicted survival or death in 
79% of cases. 
A transplant is the result of the combination of two 
complex biological systems (the donor and the reci-
pient) and their physiological and pathological status. 
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Therefore, it is better to try to identify pre-operative risk 
factors using both donor and recipient variables, instead 
of limiting the analysis to the recipient data. In our 
study, we analyzed only those parame~ers that are ob-
tained as part of a routine pre-transplant recipient and 
donor work-up. always available at the time of the do-
nor allocation. Our idea was to select simple parameters 
in a way which could be uniformly reproduced by other 
surgeons in the field. In fact, variables like encephalo-
pathy, nutritional status, and degree of ascites might be 
biased by subjective judgement, while others, like hel-
per to suppressor T cell ratio or the number of docu-
mented episodes of spontaneous bacterial peritonitis, 
might not be routinely available. 
There is a wealth of anecdotal experience regard-
ing the deleterious effects of donor hypematraemia, 
and they have recently received some support from 
clinical studies (13). In the current study, however, 
we failed to find corroborative evidence, and these re-
sults are consistent with those we obtained in a much 
larger series (21). One possible explanation for the 
perception of hypematraemia as a risk factor is the 
fact that over 60% of our donors are hypematraemic, 
as a result of the management of their neurologic 
pathology. Therefore, assuming that the probability 
of failure is the same in hyper- and normonatraemic 
donors, we should expect the majority of failed grafts 
to come from hypematremic donors (although the 
proportions would be the same). We should also point 
out that our endpoint. graft failure, is different from 
that of Gonzalez et al. (13), who studied the correla-
tion of donor serum sodium with a scoring system 
they developed. How well that scoring system corre-
lates with the probability of the graft failing is un-
clear. We still cannot rule out the possibility that ex-
treme values of donor serum sodium, either too low 
or too high, increase the risk of the graft, since the 
number of observations in the extreme ranges is rela-
tively small. Only more experience with these donors 
will provide the answer. 
The results of our multivariate analysis indicate 
that livers procured from donors older that 45 are at a 
significantly higher risk of early failure (odds ratio 
2.0. 959c CI 1.3 to 3.3). The adverse effect of increas-
ing donor age had been surmised from the start of cli-
nical liver transplantation. when a ceiling of 45 years 
was recommended for donor selection (22). Over the 
ensuing years a number of reports appeared sugge-
sting that outcome was not effected by donor age C23. 
24). Howe\er. we recently demonstrated that livers 
from donors older than 60 years have only a 439c 2-
year survival. vs 719c for the younger donors (25). A 
detailed analysis revealed that the risk of failure, as a 
function of donor age, remains constant until age 45 
years. and then increases sharply (4). The adverse in-
fluence of female donor sex was clearly demonstrated 
on the late outcome (4). 
In the current study, the livers from female donors 
did not have a worse prognosis, in terms of early out-
come (i.e., within 90 days). However, in a larger 
study we just completed, where we focused on the ef-
fect of the cytotoxic cross match, donor sex was found 
to be independently associated with early graft failure 
(21). The reasons for this discrepancy are probably 
twofold: sampling effect (462 grafts in the current 
study vs 1,520 in the crossmatch study), and slightly 
different endpoints (failure at 90 days, in the current 
study, vs failure at 180 days, in the crossmatch 
study). The different choice of endpoints was dictated 
by the problem under investigation (21). 
The two other variables that were found to be inde-
pendently associated with early graft failure were ab-
normal recipient pre-operative creatinine (greater 
than 1.5 mg/dL, odds ratio 1.9, 95% CI 1.1 to 3.2) 
and a history of previous OLTx (odds ratio 2.7, 95% 
CI 1.5 to 5.0). However, when serum creatinine was 
withheld from the logistic regression analysis, UNOS 
4 status became an independent predictor. These re-
sults, and those of recently completed studies (4, 21, 
25, 26), are helping us to lay the foundation of a bet-
ter understanding of the complex interactions that de-
termine the outcome of liver transplantation. Incident-
ally, it is instructive to see how a simple biological 
measurement, such as serum creatinine. has a greater 
explanatory power than an administrative medical ur-
gency classification system, such as UNOS status. As 
we continue to work towards refining our organ allo-
cation systems, we should strive to let the biology of 
the process lead the way. 
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